{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:37:36Z","timestamp":1782301056644,"version":"3.54.5"},"reference-count":61,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sensors"],"abstract":"<jats:p>A wearable cardioverter-defibrillator (WCD) is a temporary treatment option for patients at high risk for sudden cardiac death (SCD) and for patients who are temporarily not candidates for an implantable cardioverter defibrillator (ICD). In addition, the need for telemedical concepts in the detection and treatment of heart failure (HF) and its arrhythmias is growing. The WCD has evolved from a shock device detecting malignant ventricular arrhythmias (VA) and treating them with shocks to a heart-failure-monitoring device that captures physical activity and cardioacoustic biomarkers as surrogate parameters for HF to help the treating physician surveil and guide the HF therapy of each individual patient. In addition to its important role in preventing SCD, the WCD could become an important tool in heart failure treatment by helping prevent HF events by detecting imminent decompensation via remote monitoring and monitoring therapy success.<\/jats:p>","DOI":"10.3390\/s22010022","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T01:08:09Z","timestamp":1640135289000},"page":"22","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multiparameter Monitoring with a Wearable Cardioverter Defibrillator"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5278-6362","authenticated-orcid":false,"given":"Ursula","family":"Rohrer","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0545-4373","authenticated-orcid":false,"given":"Martin","family":"Manninger","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zirlik","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Scherr","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"ref_1","unstructured":"Mendis, S., Puska, P., Norrving, B., and World Health Organization (2011). Global Atlas on Cardiovascular Disease Prevention and Control, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_3","first-page":"e91","article-title":"AHA\/ACC\/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"72","author":"Stevenson","year":"2017","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Engl. J. Med., 337, 1576\u20131583.","DOI":"10.1056\/NEJM199711273372202"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"103F","DOI":"10.1016\/0002-9149(93)90972-F","article-title":"Canadian Implantable Defibrillator Study (CIDS): Study design and organization. CIDS Co-Investigators","volume":"72","author":"Connolly","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs. Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0002-9149(98)00120-9","article-title":"Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation","volume":"81","author":"Auricchio","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/CIRCULATIONAHA.112.146530","article-title":"Wearable cardioverter-defibrillators","volume":"127","author":"Adler","year":"2013","journal-title":"Circulation"},{"key":"ref_10","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death","volume":"138","author":"Stevenson","year":"2018","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jelectrocard.2009.05.010","article-title":"Evaluation of the effectiveness of a wearable cardioverter defibrillator detection algorithm","volume":"43","author":"Dillon","year":"2010","journal-title":"J. Electrocardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/europace\/euw180","article-title":"The wearable cardioverter-defibrillator: Current technology and evolving indications","volume":"19","author":"Reek","year":"2017","journal-title":"Europace"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/clc.23288","article-title":"Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator","volume":"43","author":"Burch","year":"2020","journal-title":"Clin. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cpcardiol.2017.04.002","article-title":"Wearable Cardioverter Defibrillator \u201cThe Lifevest\u201d: Device Design, Limitations, and Areas of Improvement","volume":"43","author":"Agarwal","year":"2018","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ihj.2013.12.050","article-title":"Wearable cardioverter defibrillator: A life vest till the life boat (ICD) arrives","volume":"66","author":"Francis","year":"2014","journal-title":"Indian Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1540-8159.2004.00378.x","article-title":"Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: Results of the WEARIT\/BIROAD","volume":"27","author":"Feldman","year":"2004","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.115.015677","article-title":"Use of the wearable cardioverter defibrillator in high-risk cardiac patients: Data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)","volume":"132","author":"Kutyifa","year":"2015","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.115.019124","article-title":"Experience with the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death","volume":"134","author":"Wassnig","year":"2016","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacc.2010.04.016","article-title":"Aggregate national experience with the wearable cardioverter-defibrillator: Event rates, compliance, and survival","volume":"56","author":"Chung","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1474515118790365","article-title":"Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: Results of the Austrian WCD Registry","volume":"18","author":"Odeneg","year":"2019","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/jce.13229","article-title":"Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT)","volume":"28","author":"Barsheshet","year":"2017","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kao, A.C., Krause, S.W., Handa, R., Karia, D., and Reyes, G. (2012). Bianco Wearable defibrillator use in heart failure (WIF): Results of a prospective registry. BMC Cardiovasc. Disord., 12.","DOI":"10.1186\/1471-2261-12-123"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.jacc.2015.09.079","article-title":"Utility of the Wearable Cardioverter-Defibrillator in Patients with Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience","volume":"66","author":"Singh","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.amjcard.2011.07.021","article-title":"Wearable defibrillator in congenital structural heart disease and inherited arrhythmias","volume":"108","author":"Rao","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ejhf.188","article-title":"Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter\/defibrillator","volume":"16","author":"Duncker","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cardfail.2011.09.004","article-title":"Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator","volume":"18","author":"Saltzberg","year":"2012","journal-title":"J. Card. Fail."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCEP.112.973552","article-title":"Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator","volume":"6","author":"Zishiri","year":"2013","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jelectrocard.2017.04.017","article-title":"A real world wearable cardioverter defibrillator experience\u2014Very high appropriate shock rate in ischemic cardiomyopathy patients at a European single-center","volume":"50","author":"Beiert","year":"2017","journal-title":"J. Electrocardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.jacc.2013.05.086","article-title":"Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction","volume":"62","author":"Epstein","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","article-title":"Wearable Cardioverter-Defibrillator after Myocardial Infarction","volume":"379","author":"Olgin","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jce.14404","article-title":"Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses","volume":"31","author":"Olgin","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1111\/jce.14746","article-title":"Neglected lead tip erosion: An unusual case of S-ICD inappropriate shock","volume":"31","author":"Mitacchione","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/CIR.0000000000000394","article-title":"Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory from the American Heart Association","volume":"133","author":"Piccini","year":"2016","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12181-019-0331-4","article-title":"Der tragbare Kardioverter\/Defibrillator (WCD)\u2014Indikationen und Einsatz","volume":"13","author":"Deneke","year":"2019","journal-title":"Kardiologe"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1540-8159.2009.02590.x","article-title":"Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD)","volume":"33","author":"Klein","year":"2010","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00380-018-1181-x","article-title":"Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort","volume":"33","author":"Zylla","year":"2018","journal-title":"Heart Vessels"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/pace.12986","article-title":"Safety of the Wearable Cardioverter Defibrillator (WCD) in Patients with Implanted Pacemakers","volume":"40","author":"Schmitt","year":"2017","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00508-017-1290-z","article-title":"Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation","volume":"129","author":"Manninger","year":"2017","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_39","first-page":"1346","article-title":"Incidence and predictors of alarms in patients with wearable cardioverter defibrillator (WCD)\u2014Results of the Austrian WCD Registry","volume":"40","author":"Odeneg","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00392-016-1054-1","article-title":"The wearable cardioverter-defibrillator in a real-world clinical setting: Experience in 102 consecutive patients","volume":"106","author":"Erath","year":"2017","journal-title":"Clin. Res. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1542-474X.2012.00531.x","article-title":"Multicenter automatic defibrillator implantation trial: Reduce inappropriate therapy (MADIT-RIT): Background, rationale, and clinical protocol","volume":"17","author":"Schuger","year":"2012","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_42","first-page":"93","article-title":"Telemedical Concepts for Heart Failure Patients Treated with a Wearable Cardioverter Defibrillator","volume":"271","author":"Reiss","year":"2020","journal-title":"Stud. Health Technol. Inform."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCHEARTFAILURE.109.885210","article-title":"Recent national trends in readmission rates after heart failure hospitalization","volume":"3","author":"Ross","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.amjcard.2015.11.048","article-title":"Meta-Analysis of Risks for Short-Term Readmission in Patients with Heart Failure","volume":"117","author":"Saito","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","article-title":"Transition from chronic compensated to acute decompensated heart failure: Pathophysiological insights obtained from continuous monitoring of intracardiac pressures","volume":"118","author":"Zile","year":"2008","journal-title":"Circulation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(14)61176-4","article-title":"Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): A randomised controlled trial","volume":"384","author":"Hindricks","year":"2014","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","article-title":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: Complete follow-up results from the CHAMPION randomised trial","volume":"387","author":"Abraham","year":"2016","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1002\/ehf2.13045","article-title":"Influence of decompensated heart failure on cardiac acoustic biomarkers: Impact on early readmissions","volume":"7","author":"Erath","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mueller-Leisse, J., Brunn, J., Zormpas, C., Hohmann, S., Hillmann, H.A.K., Eiringhaus, J., Bauersachs, J., Veltmann, C., and Duncker, D. (2021). Extended follow-up after wearable cardioverter-defibrillator period: The PROLONG-II study. ESC Heart Fail.","DOI":"10.1002\/ehf2.13586"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Hillmann, H.A.K., Hohmann, S., Mueller-Leisse, J., Zormpas, C., Eiringhaus, J., Bauersachs, J., Veltmann, C., and Duncker, D. (2021). Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter\u2013Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction. Sensors, 21.","DOI":"10.3390\/s21237798"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e010108","DOI":"10.1161\/JAHA.118.010108","article-title":"Increased Physical Activity Post-Myocardial Infarction Is Related to Reduced Mortality: Results from the SWEDEHEART Registry","volume":"7","author":"Ekblom","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.amjcard.2014.01.430","article-title":"Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure","volume":"113","author":"Vegh","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.113.000883","article-title":"Physical activity measured with implanted devices predicts patient outcome in chronic heart failure","volume":"7","author":"Conraads","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.hroo.2020.06.004","article-title":"Decline in physical activity in the weeks preceding sustained ventricular arrhythmia in women","volume":"1","author":"Burch","year":"2020","journal-title":"Heart Rhythm. O2"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/HCR.0000000000000454","article-title":"Physical Activity in Adults with Wearable Cardioverter Defibrillators in the Post-Myocardial Infarction Period","volume":"40","author":"Tripp","year":"2020","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00399-021-00769-0","article-title":"Der Wearable Kardioverter-Defibrillator als Diagnostikum","volume":"32","author":"Pulickal","year":"2021","journal-title":"Herzschrittmachertherapie Elektrophysiologie"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e004512","DOI":"10.1161\/JAHA.116.004512","article-title":"Avoiding Untimely Implantable Cardioverter\/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter\/Defibrillator-The PROLONG Study","volume":"6","author":"Duncker","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tcm.2020.03.002","article-title":"Wearable cardioverter-defibrillators: A review of evidence and indications","volume":"31","author":"Cheung","year":"2021","journal-title":"Trends Cardiovasc. Med."}],"container-title":["Sensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8220\/22\/1\/22\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:50:46Z","timestamp":1760169046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8220\/22\/1\/22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["s22010022"],"URL":"https:\/\/doi.org\/10.3390\/s22010022","relation":{},"ISSN":["1424-8220"],"issn-type":[{"value":"1424-8220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}